Role of insulin-like growth factors in neuronal plasticity and neuroprotection

Advances in Experimental Medicine and Biology

Volumn 567, Issue , 2005, Pages 243-258

  Aleman, Ignacio Torres ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Brain function; Nerve cell plasticity; Neuro repair; Neurodegenerative diseases; Synaptic contacts

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN C; GROWTH HORMONE;

ANGIOGENESIS; DRUG MECHANISM; HORMONAL REGULATION; HORMONE ACTION; HUMAN; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; REVIEW; ANIMAL; NERVOUS SYSTEM FUNCTION; PHYSIOLOGY;

ANIMALS; GROWTH HORMONE; HUMANS; NERVOUS SYSTEM PHYSIOLOGY; NEURONAL PLASTICITY; SOMATOMEDINS;

EID: 33644806375     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-26274-1_10     Document Type: Review

References (92)

1. M.J. Abuzzahab, A. Schneider, A. Goddard, F. Grigorescu, C. Lautier, E. Keller, W. Kiess, J. Klammt, J. Kratzsch, D. Osgood, R. Pfaffle, K. Raile, B. Seidel, R.J. Smith and S.D. Chernausek, IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med, 349, 2211-2222 (2003).
2. P. Aebischer and J. Ridet, Recombinant proteins for neurodegenerative diseases: the delivery issue. Trends Neurosci, 24, 533-540 (2001).
3. I.K. Andersson, D. Edwall, G. Norstedt, B. Rozell, A. Skottner and H.A. Hansson, "Differing expression of insulin-like growth factor I in the developing and in the adult rat cerebellum," Acta Physiol Scand. 132, 167-173 (1988).
4. R.J. Armstrong and R.A. Barker, Neurodegeneration: a failure of neuroregeneration? Lancet, 358, 1174-1176 (2001).
5. R. Baffa, K. Reiss, E.A. El Gabry, J. Sedor, M.L. Moy, D. Shupp-Byrne, S.E. Strup, W.W. Hauck, R. Baserga and L.G. Gomella, Low serum insulin-like growth factor 1 (IGF-1): a significant association with prostate cancer. Tech Urol, 6, 236-239 (2000).
6. W.P. Bartlett, X.S. Li, M. Williams and S. Benkovic, Localization of insulin-like growth factor-1 mRNA in murine central nervous system during postnatal development. Dev Biol, 147, 239-250 (1991).
7. K.D. Beck, L. Powell-Braxton, H.R. Widmer, J. Valverde and F. Hefti, Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron, 14, 717-730 (1995).
8. P. Bezzi and A. Volterra, A neuron-glia signalling network in the active brain. Curr Opin Neurobiol, 11, 387-394 (2001).
9. L.A. Blair and J. Marshall, IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner. Neuron, 19, 421-429 (1997).
10. C.A. Bondy, Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci, 11, 3442-3455 (1991).
11. C.A. Bondy and W.H. Lee, Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann NY Acad Sci, 692, 33-43 (1993).
12. D.J. Bonthius, B. Karacay, D. Dai and N.J. Pantazis, FGF-2, NGF and IGF-1, but not BDNF, utilize a nitric oxide pathway to signal neurotrophic and neuroprotective effects against alcohol toxicity in cerebellar granule cell cultures. Brain Res Dev Brain Res, 140, 15-28 (2003).
13. D.V. Buonomano and M.M. Merzenich, Cortical plasticity: from synapses to maps. Annu Rev Neurosci, 21, 149-186 (1998).
14. C. Camacho-Hubner, K.A. Woods, A.J. Clark and M.O. Savage, Insulin-like growth factor (IGF)-I gene deletion. Rev Endocr Metab Disord, 3, 357-361 (2002).
15. I. Torres-Alemán and Carro E, "Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects? Exp Rev Neurotherapy, (in press).
16. E. Carro, A. Nunez, S. Busiguina and I. Torres-Aleman, Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci, 20, 2926-2933 (2000).
17. E. Carro, J.L. Trejo, S. Busiguina and I. Torres-Aleman, Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci, 21, 5678-5684 (2001).
18. E. Carro, J.L. Trejo, T. Gomez-Isla, D. LeRoith, and I. Torres-Aleman, Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med, (2002).
19. E. Carro, J.L. Trejo, A. Nunez and I. Torres-Aleman, Brain repair and neuroprotection by serum insulin-like growth factor I. Mol Neurobiol, 27, 153-162 (2003).
20. R.C. Carroll, E.C. Beattie, M. Von Zastrow and R.C. Malenka, Role of AMPA receptor endocytosis in synaptic plasticity. Nat Rev Neurosci, 2, 315-324 (2001).
21. M.J. Carson, R.R. Behringer, R.L. Brinster and F.A. McMorris, Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron, 10, 729-740 (1993).
22. M.A. Castro-Alamancos and I. Torres-Aleman, Long-term depression of glutamate-induced gamma-aminobutyric acid release in cerebellum by insulin-like growth factor I. Proc Natl Acad Sci USA, 90, 7386-7390 (1993).
23. B. Cheng and M.P. Mattson, IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci, 12, 1558-1566 (1992).
24. C.M. Cheng, R.R. Reinhardt, W.H. Lee, G. Joncas, S.C. Patel and C.A. Bondy, Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc Natl Acad Sci USA, 97, 10236-10241 (2000).
25. G. Clarke, R.A. Collins, B.R. Leavitt, D.F. Andrews, M.R. Hayden, C.J. Lumsden and R.R. McInnes, A one-hit model of cell death in inherited neuronal degenerations. Nature, 406, 195-199 (2000).
26. A.M. Corse, M.M. Bilak, S.R. Bilak, M. Lehar, J.D. Rothstein and R.W. Kuncl, Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration. Neurobiol Dis, 6, 335-346 (1999).
27. A.J. D'Ercole, P. Ye and G. Gutierrez-Ospina, Use of transgenic mice for understanding the physiology of insulin-like growth factors. Horm Res, 45 Suppl 1, 5-7 (1996).
28. R. Dantzer, G. Gheusi, R.W. Johnson and K.W. Kelley, Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide- induced sickness behavior in mice. Neuroreport, 10, 289-292 (1999).
29. F. de Pablo and E.J. de la Rosa, The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci, 18, 143-150 (1995).
30. K. DeLellis, S. Ingles, L. Kolonel, R. McKean-Cowdin, B. Henderson, F. Stanczyk and N.M. Probst-Hensch, "IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer, 88, 277-282 (2003).
31. H. Dudek, S.R. Datta, T.F. Franke, M.J. Birnbaum, R. Yao, G.M. Cooper, R.A. Segal, D.R. Kaplan and M.E. Greenberg, Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 275, 661-665 (1997).
32. A.M. Fernandez, A.G. de la Vega and I. Torres-Aleman, Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia. Proc Natl Acad Sci USA, 95, 1253-1258 (1998).
33. A.M. Fernandez, A.G. Gonzalez de la Vega, B. Planas and I. Torres-Aleman, Neuroprotective actions of peripherally administered insulin-like growth factor I in the injured olivo-cerebellar pathway. Eur J Neurosci, 11, 2019-2030 (1999).
34. C. Gamboa and A. Ortega, Insulin-like growth factor-1 increases activity and surface levels of the GLAST subtype of glutamate transporter. Neurochem Int, 40, 397-403 (2002).
35. E. Garcia-Galloway, C. Arango, S. Pons and I. Torres-Aleman, Glutamate excitotoxicity attenuates insulin-like growth factor-i prosurvival signaling. Mol Cell Neurosci, 24, 1027-1037 (2003).
36. L.M. Garcia-Segura, J. Perez, S. Pons, M.T. Rejas and I. Torres-Aleman, Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res, 560, 167-174 (1991).
37. C.M. Gillespie, A.L. Merkel and A.A. Martin, Effects of insulin-like growth factor-I and LR3IGF-I on regional blood flow in normal rats. J Endocrinol, 155, 351-358 (1997).
38. D.L. Gonzalez, W. Buno, S. Pons, M.S. Garcia-Calderat, E. Garcia-Galloway and I. Torres-Aleman, Insulin-like growth factor I potentiates kainate receptors through a phosphatidylinositol 3-kinase dependent pathway. Neuroreport, 12, 1293-1296 (2001).
39. S. Grinspoon, K. Miller, D. Herzog, D. Clemmons and A. Klibanski, Effects of Recombinant Human Insulin-Like Growth Factor (IGF)-I and Estrogen Administration on IGF-I, IGF Binding Protein (IGFBP)-2, and IGFBP-3 in Anorexia Nervosa: A Randomized-Controlled Study. J Clin Endocrinol Metab, 88, 1142-1149 (2003).
40. J. Guan, L. Bennet, P.D. Gluckman and A.J. Gunn, Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol, 70, 443-462 (2003).
41. K.M. Guthrie, T. Nguyen and C.M. Gall, Insulin-like growth factor-1 mRNA is increased in deafferented hippocampus: spatiotemporal correspondence of a trophic event with axon sprouting. J Comp Neurol, 352, 147-160 (1995).
42. C. Hawkes and S. Kar, Insulin-like growth factor-II/mannose-6-phosphate receptor: widespread distribution in neurons of the central nervous system including those expressing cholinergic phenotype. J Comp Neurol, 458, 113-127 (2003).
43. S. Heck, F. Lezoualc'h, S. Engert and C. Behl, Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem, 274, 9828-9835 (1999).
44. S. Humbert, E.A. Bryson, F.P. Cordelieres, N.C. Connors, S.R. Datta, S. Finkbeiner, M.E. Greenberg and F. Saudou, The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell, 2, 831-837 (2002).
45. M.A. Hynes, P.J. Brooks, J.J. Van Wyk and P.K. Lund, Insulin-like growth factor II messenger ribonucleic acids are synthesized in the choroid plexus of the rat brain. Mol Endocrinol, 2, 47-54 (1988).
46. M. Kanje, A. Skottner, J. Sjoberg and G. Lundborg, Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res, 486, 396-398 (1989).
47. M. Kanzaki, Y.Q. Zhang, H. Mashima, L. Li, H. Shibata and I. Kojima, Translocation of a calcium-permeable cation channel induced by insulin- like growth factor-I. Nat Cell Biol, 1, 165-170 (1999).
48. B.K. Kaspar, J. Llado, N. Sherkat, J.D. Rothstein and F.H. Gage, Retrograde viral delivery of IGF-I prolongs survival in a mouse ALS model. Science, 301, 839-842 (2003).
49. I. Kazanis, E. Bozas, H. Philippidis and F. Stylianopoulou, Neuroprotective effects of insulin-like growth factor-I (IGF-I) following a penetrating brain injury in rats. Brain Res, 991, 34-45 (2003).
50. W. Kelsch, S. Hormuzdi, E. Straube, A. Lewen, H. Monyer and U. Misgeld, Insulin-like growth factor 1 and a cytosolic tyrosine kinase activate chloride outward transport during maturation of hippocampal neurons. J Neurosci, 21, 8339-8347 (2001).
51. G. Kempermann, Why new neurons? Possible functions for adult hippocampal neurogenesis. J Neurosc, 22, 635-638 (2002).
52. E.C. Lai, K.J. Felice, B.W. Festoff, M.J. Gawel, D.F. Gelinas, R. Kratz, M.F. Murphy, H.M. Natter, F.H. Norris and S.A. Rudnicki, Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology, 49, 1621-1630 (1997).
53. W.H. Lee, S. Javedan and C.A. Bondy, Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development. J Neurosci, 12, 4737-4744 (1992).
54. W.H. Lee, K.M. Michels and C.A. Bondy, Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II. Neuroscience, 53, 251-265 (1993).
55. K.R. Leslie, S.B. Nelson and G.G. Turrigiano, Postsynaptic depolarization scales quantal amplitude in cortical pyramidal neurons. J Neurosci, 21, RC170 (2001).
56. M. Lijffijt, P.S. van Dam, J.L. Kenemans, H.P. Koppeschaar, W.R. de Vries, M.L. Drent, A. Wittenberg and C. Kemner, Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients. Neurosci Lett, 353, 123-126 (2003).
57. J.C. Liou, F.Z. Tsai and S.Y. Ho, Potentiation of quantal secretion by insulin-like growth factor-1 at developing motoneurons in Xenopus cell culture. J Physiol, (2003).
58. S.B. Lupien, E.J. Bluhm and D.N. Ishii, Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J. Neurosci Res, 74, 512-523 (2003).
59. K.B. Mackay, S.A. Loddick, G.S. Naeve, A.M. Vana, G.M. Verge and A.C. Foster, Neuroprotective Effects of Insulin-Like Growth Factor-Binding Protein Ligand Inhibitors in Vitro and in Vivo. J Cereb Blood Flow Metab, 23, 1160-1167 (2003).
60. Y.H. Man, J.W. Lin, W.H. Ju, G. Ahmadian, L. Liu, L.E. Becker, M. Sheng, and Y.T. Wang, Regulation of AMPA receptor-mediated synaptic transmission by clathrin- dependent receptor internalization. Neuron, 25, 649-662 (2000).
61. S. Manes, E. Mira, C. Gomez-Mouton, R.A. Lacalle, P. Keller, J.P. Labrador and A. Martinez, Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J, 18, 6211-6220 (1999).
62. A.L. Markowska, M. Mooney and W.E. Sonntag, Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience, 87, 559-569 (1998).
63. P.A. McKelvie, K.M. Rosen, H.C. Kinney and L. Villa-Komaroff, Insulin-like growth factor II expression in the developing human brain. J Neuropathol Exp Neurol, 51, 464-471 (1992).
64. J.D. Mitchell, J.H. Wokke and G.D. Borasio, Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease (Cochrane Review). Cochrane Database Syst Rev, CD002064 (2002).
65. P. Mitchell, Cancelled IGF-I trials bode ill for diabetic patients. Lancet, 350, 1606 (1997).
66. W. Ni, K. Rajkumar, J.I. Nagy and L.J. Murphy, Impaired brain development and reduced astrocyte response to injury in transgenic mice expressing IGF binding protein-1. Brain Res, 769, 97-107 (1997).
67. M.P. Nieto-Bona, L.M. Garcia-Segura and I. Torres-Aleman, Transynaptic modulation by insulin-like growth factor 1 of dendritic spines in Purkinje cells. Int J Dev Neurosci, 15, 749-754 (1997).
68. T. Niikura, Y. Hashimoto, T. Okamoto, Y. Abe, T. Yasukawa, M. Kawasumi, T. Hiraki, Y. Kita, K. Terashita, K. Kouyama and I. Nishimoto, Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J Neurosci, 21, 1902-1910 (2001).
69. R.J. Nudo, G.W. Milliken, W.M. Jenkins and M.M. Merzenich, Use-dependent alterations of movement representations in primary motor cortex of adult squirrel monkeys. J Neurosci, 16, 785-807 (1996).
70. A. Nunez, E. Carro, and I. Torres-Aleman, Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J Neurophysiol, 89, 3008-3017 (2003).
71. S. Pons and I. Torres-Aleman, Insulin-like Growth Factor-I Stimulates Dephosphorylation of Ikappa B through the Serine Phosphatase Calcineurin (Protein Phosphatase 2B). J Biol Chem, 275, 38620-38625 (2000).
72. B.E. Pulford, L.R. Whalen and D.N. Ishii, Peripherally administered insulin-like growth factor-I preserves hindlimb reflex and spinal cord noradrenergic circuitry following a central nervous system lesion in rats. Exp Neurol, 159, 114-123 (1999).
73. K. Sakagami, D.M. Wu and D.G. Puro, Physiology of rat retinal pericytes: modulation of ion channel activity by serum-derived molecules. J Physiol, 521 Pt 3, 637-650 (1999).
74. A. Savchenko, T.W. Kraft, E. Molokanova and R.H. Kramer, Growth factors regulate phototransduction in retinal rods by modulating cyclic nucleotide-gated channels through dephosphorylation of a specific tyrosine residue. Proc Natl Acad Sci USA, 98, 5880-5885 (2001).
75. R.E. Schmidt, D.A. Dorsa, L.N. Beaudet, S.B. Plurad, C.A. Parvin and M.S. Miller, Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. Am. J. Pathol. 155, 1651-1660 (1999).
76. D. Seto, W.H. Zheng, A. McNicoll, B. Collier, R. Quirion and S. Kar, Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience, 115, 603-612 (2002).
77. U. Sonnewald, A.Y. Wang, S.B. Petersen, N. Westergaard, A. Schousboe, R. Erikson and A. Skottner, 13C NMR study of IGF-I- and insulin-effects on mitochondrial function in cultured brain cells. Neuroreport, 6, 878-880 (1995).
78. W.E. Sonntag, S.A. Bennett, A.S. Khan, P.L. Thornton, X. Xu, R.L. Ingram and J.K. Brunso-Bechtold, Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats. Brain Res Bull, 51, 331-338 (2000).
79. T. Standal, M. Borset, S. Lenhoff, F. Wisloff, B. Stordal, A. Sundan, A. Waage and C. Seidel, Serum insulin-like growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor, Blood, (2002).
80. K.A. Sullivan and E.L. Feldman, Immunohistochemical localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 during development in the rat brain. Endocrinology, 135, 540-547 (1994).
81. H. Thoenen, Neurotrophins and neuronal plasticity. Science, 270, 593-598 (1995).
82. H. Thoenen and M. Sendtner, Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci, 5 Suppl, 1046-1050 (2002).
83. I. Torres-Aleman. Serum growth factors and neuroprotective surveillance. Mol Neurobiol, 21, 153-160 (2000).
84. I. Torres-Aleman and A.M. Fernandez, The role of insulin-like growth factors in human neurodegeneration. (Springer Publishing Co., 1998), 131-149.
85. J.L. Trejo, E. Carro, E. Garcia-Galloway and I. Torres-Aleman, Role of insulin-like growth factor I signaling in neurodegenerative diseases. J Mol Med (2003).
86. P.S. van Dam, A. Aleman, W.R. de Vries, J.B. Deijen, E.A. van der Veen, E.H. de Haan and H.P. Koppeschaar, Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm IGF Res, 10 Suppl B, S69-S73 (2000).
87. B. Voutsinos-Porche, G. Bonvento, K. Tanaka, P. Steiner, E. Welker, J.Y. Chatton, P.J. Magistretti and L. Pellerin, Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex. Neuron, 37, 275-286 (2003).
88. Q. Wan, Z.G. Xiong, H.Y. Man, C.A. Ackerley, J. Braunton, W.Y. Lu, L.E. Becker, J.F. MacDonald, and Y.T. Wang, Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature, 388, 686-690 (1997).
89. K. Woodson, J.A. Tangrea, M. Pollak, T.D. Copeland, P.R. Taylor, J. Virtamo, and D. Albanes, Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Cancer Res, 63, 3991-3994 (2003).
90. A. Yamaguchi, M. Tamatani, H. Matsuzaki, K. Namikawa, H. Kiyama, M.P. Vitek, N. Mitsuda, and M. Tohyama, Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem, 276, 5256-5264 (2001).
91. H.X. Zhuang, C.K. Snyder, S.F. Pu, and D.M. Ishii, Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol, 140, 198-205 (1996).
92. C. Zona, M.T. Ciotti, and P. Calissano, Human recombinant IGF-1 induces the functional expression of AMPA/kainate receptors in cerebellar granule cells. Neurosci Lett, 186, 75-78 (1995).